NNovo Nordisk Read More Oral Ozempic Hits Pharmacies as Earnings Test Investor Patience2026-05-04 Novo Nordisk launches oral Ozempic in the US amid Q1 earnings decline, Eli Lilly competition, and patent pressures.…